<DOC>
	<DOCNO>NCT00578006</DOCNO>
	<brief_summary>Cancer patient may develop side effect treatment , nausea , pain , fatigue , diarrhea , constipation , shortness breath . These symptom may due cancer , due treatment like chemotherapy drug radiation therapy . Doctors nurse often ask patient symptom , important part cancer treatment make patient feel well possible . If patient feel well , investigator may need change way investigator treat prescribe therapy decrease symptom . The best way find feeling ask directly . However , time appointment investigator may able ask feel regular basis . In addition , even appointment , may symptoms investigator chance discus . The investigator interested develop new way ask patient feel , use Internet . A special new website call STAR ( `` Symptom Tracking Reporting Patients '' ) develop help patient record information , doctor nurse review clinic appointment . This study design help u see STAR helpful way u keep track information patient ' symptom quality life .</brief_summary>
	<brief_title>Internet-based System Cancer Patients Self-report Toxicity</brief_title>
	<detailed_description>This pilot study ass patient use STAR ( Symptom Tracking Reporting Patients ) , online system design cancer patient self-record toxicity-related symptom base NCI Common Terminology Criteria Adverse Events v3.0 , performance status ECOG criterion , global quality life EuroQOL 5-D assessment tool , emergency room visit , survival . Secondary outcome include patient assessment usefulness STAR , clinician perception potential value STAR routine clinical practice , evaluation whether STAR improve patient experience care assessed satisfaction measure .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Diagnosis gynecologic ( ovarian ; cervical ; uterine ; primary peritoneal ) , lung ( nonsmall cell ; small cell ) , gastrointestinal ( colorectal , rectal , gastric , esophageal , GI neuroendocrine , small intestine malignancy , pancreatic , hepatocellular ) , breast , bladder cancer prostate malignancy Receiving primary medical oncology care MSKCC medical oncology outpatient clinic Receiving cytotoxic chemotherapy clinical trial ( new hormonal therapy case prostate cancer patient ) , treatment expect continue least four week time enrollment Signed informed consent Research Authorization ECOG performance status great 2 Unable read comprehend English language text</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>toxicity relate symptom</keyword>
	<keyword>04-020</keyword>
</DOC>